Molecular Analysis of the IDEAL/INTACT trials: EGFR Mutations and Gene Amplification

Reviewer: S. Jack Wei, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 15 de mayo del 2005

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Genes Identified for Ovarian Cancer Prognosis

Apr 16, 2012

Validated bimodal genes can define relevant molecular subtypes of ovarian cancer

EGFR Mutation Abundance Affects Therapy in NSCLC

Jul 29, 2011

Progression-free survival significantly longer in patients with high abundance of EGFR mutations

New Method Improves BRCA1/2 Mutation Detection

Aug 8, 2012

Next-generation sequencing, which includes long-range PCR, is quick, accurate, and inexpensive